3i Deutschland
3i France
3i Group
3i Switzerland
4SC AG
A M Pappas & Associates
Abingworth Management
Ablynx
ABN AMRO Capital Life Sciences
Accelsiors Group International
ACE BioSciences
Acrux Limited
Actelion Pharmaceuticals
Adamant Biomedical Investments
Addex Pharmaceuticals SA
Advent Venture Partners
Affentranger Associates
Affibody AB
Affimed Therapeutics
AGF Private Equity
AKALPA, R. Toder & Partner in Lifesciences
Alice Ventures
ALPHA Associates
Alta Berkeley
Amarin Corporation
American Stock Exchange
Amsterdam Molecular Therapeutics
Apit Laboratories GmbH
Apoxis
Aravis Venture Association
Archemix
Ardana
Arpida
Artimplant AB
ASCOMP
Atila Ventures
Atlas Venture
Austrianova
AVIDA Group
Avidex
Bank Julius Baer
Bank Leu
Bank Sarasin & Co
Bank Vontobel
BankInvest Group
Barcelona Empren
Bay City Capital
Bayhill Therapeutics
BayTech Venture Capital
BB Medtech
Bellevue Asset Management
Bioaccelerate
BioAssociés Sarl
Biobase
BioConnect
Biogen Idec International GmbH
Bio-M
BioMedinvestor
BioMS Medical Corp.
BioNet Holding GmbH
Bionor Immuno
Biophan Technologies
Biopolo Ticino
BioPure
Bioscience Managers
Biotech Center Zurich
Biotie Therapies Corp.
BioTOP Berlin-Brandenburg
BioValley - Basel Area Business Dev.
Biovertis
BioVex
BioXell
Bloomberg
Blue Corporate Finance GmbH & Co
BOREAN PHARMA
BRESLIN
Bristol Myers Squibb
BW-Venture Capital
Canadian Embassy
Capital Dynamics
CDC IXIS Innovation
Celares GmbH
Cellerix
Chroma Therapeutics
Citigate Dewe Rogerson
Clear Capital
Clearant
Clubb Capital
Code Securities Limited
CogState
Coller Capital
Combinature Biopharm
Creathor Venture
CREDIT AGRICOLE PRIVATE EQUITY
Credit Suisse
Credit Suisse First Boston
Credit Suisse Private Banking
Curacyte AG
Cyberkinetics
Deodora Pharma
Deutsche Bank AG
Deutsche Börse AG
DeveloGen
Diamyd Medical
Diatos
DIREVO Biotech
DKR Capital
DMS Data Systems
Dow Jones
DVC Deutsche Venture Capital
DyoDelta
Earlybird Venture Capital
Economic Development Canton of Zurich
Egamid
Elbion AG
EMBL Ventures
Equicore Beteiligungs
Ernst & Young
ESBATech
Euramedics BVBA
Evolutec Group
Evotec OAI
F. Hoffmann-La Roche Ltd.
FaustPharmaceuticals
Favrille
Ferghana Partners
Forenap Pharma
Fresenius
Futura Medical
Galenica
gamma capital parters
Ganymed Pharmaceuticals AG
Generex Biotechnology
Genevest
Genzyme
GGA Software Services
Gilde Healthcare
Gilde Investment Management
GIMV NV
Global Life Science Ventures
GLYCART biotechnology
Glycotope GmbH
GlycoVaxyn AG
Greater Zurich Area
HBM Partners
Heidelberg Innovation
Heidelberg Pharma GmbH
High Tech Private Equity GmbH
IBG
immatics biotechnologies
ImVisioN
Index Ventures
Ingenium Pharmaceuticals
Innoven Partenaires
Insinger de beaufort
Institute of Biotechnology
Institute of Brain Research
IntegraGen
Intercell
Inventages Venture Capital
Investment New Zealand
IR - Buth
IsoTis
ITX Corporation
Jado Technologies
Katan Associates
Kepler Equities
Kirchhoff Consult AG
Kuros Biosurgery AG
Laboratoires Fournier
LB (Swiss) Private Bank
LBBW
Lehman Brothers
LGT Capital Partners Ltd.
Lloyds TSB Corporate, Technology & Life Sciences
Lombard Odier Darier Hentsch & Cie
Matignon Investissement et Gestion
Mattern Pharmaceuticals AG
Mayors office Zurich
Med Services Europe GmbH
Medicis Ventures
Medtronic Europe
MedWork AG
Merck
Merrimack Pharmaceuticals
Millennium Ventures
MNLpharma
Molecular Partners
mondoBIOTECH
Morgan Stanley
mtm laboratories
Mulligan BioCapital
NeoMed Management
NEURAXO BIOTEC GmbH
Neuro3d
Newron Pharmaceuticals SpA
Nextech Venture
NGN Capital
Nomura
Northbank Communications Ltd
Novadaq Technologies
Novartis Pharmaceuticals
Novartis Venture Fund
NRW Bank
NZB Neue Zürcher Bank
Oakes, Lyman & Co. Limited
Omega Fund
Oncolytics Biotech
Osprey Capital Partners
OT Consultant
Patentanwaltgesellschaft mbH Bosch, Graf von Stosch, Jehle
Paul Capital Partners
PEPPERMINT Holding GmbH
Perseus-Soros Biopharmaceutical Fund
Pevion Biotech
PIERIS Proteolab AG
Plant Health Care plc
Plethora Solutions
Polyphor
PolyTechnos Venture - Partners
PricewaterhouseCoopers
Private Equity - Investments & Advisory Services
Probiodrug AG
ProMedica Investments
ProtAffin Biotechnologie AG
Quest Management
RCC
Rentschler Biotechnologie GmbH
Reuters
RiboVax Biotechnologies
RNAx GmbH
Rochat & Partners
Sal. Oppenheim Jr. & Cle.
Santaris Pharma
Santaris Pharma
Santhera Pharmaceuticals
Schweizerhall Management AG
Scil Technology
Scottish Equity Partners
Scottish Widows Investment Partnership
SEED
Serono International
SG Cowen
Shire Pharmaceuticals Group
Sidec Technologies
Siegfried Biologics
Siemens Medical Solutions
SJ Berwin
Skintek AG
Sofinnova
South East Growth Fund
Speedel
SPEF Venture
suterscience/BioValley - European Centre of Pharmaceutical Medicine
suterscience/BioValley Basel
SweTree Technologies
Swiss Biotech Association
Swiss Equity Magazine
Swiss Medica
SWX
Syngenta Biopharma
SyntheMed
Tech Investor
Techno Venture Management (TVM)
Technology Consulting
The Aethena Group
The BioScience Ventures
The Genetics Company, Inc.
The Trout Group LLC
Thurn und Taxis Capital Management
Transgene
UBS AG
Union Bancair Privée
Ventech
Venture Valuation
VI Partners
Vida Capital Partners
Vontobel Securities
Warburg Pincus
Wedge Associates
Wellington Partners
Wenger & Vieli
Widmann Associates
Xantos Biomedicine
XL Tech Group
YM Biosciences